News

SEC Filings

Document Details

Form
Filing Date
March 10, 2021
Document Date
March 3, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Pierce Valerie L

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com